As weight-loss medications like Ozempic, Wegovy, and Mounjaro enter the employee benefits landscape, a new equity dilemma is challenging UK employers. New research from Lifesum, a global nutrition app, reveals that the vast majority of UK employees are concerned that providing these medications in the workplace will widen existing health inequalities.
The survey of 2,000 UK employees found that 74% believe workplace provision of GLP-1s could increase the health gap, while only 21% think it could help level the playing field. This finding issues a stark warning to HR leaders that benefit design must be inclusive and sensitive to employee perceptions of fairness.
The Human Side of the GLP-1 Debate
While the UK currently has about 2.9% of adults using a GLP-1 for weight loss, the discussion around employer-sponsored programs is complex, highlighting nuanced emotional and social dynamics:
| UK Employee Reaction to Employer-Provided GLP-1s | Percentage |
| Grateful | 27% |
| Concerned | 23% |
| Pressured | 16% |
| Neutral | 47% |
The mix of gratitude and anxiety (with 39% feeling either concerned or pressured) underscores that introducing these benefits requires careful, empathetic communication to avoid creating a stigmatized or mandated workplace expectation.
Focus vs. Lifestyle: What Employees Believe
Employees also expressed skepticism regarding the long-term, non-medical benefits often touted by employers:
- Only 20% believe GLP-1s will boost focus or reduce absenteeism.
- 50% strongly believe lifestyle factors (like nutrition and exercise) are the real drivers of these health outcomes.
This reinforces the view of Cecilia Hellström, Workplace Well-being Director at Lifesum: “No single solution replaces long-term nutrition. Access alone isn’t enough.”
Strategic Imperatives for Equitable GLP-1 Programs
The research provides a clear mandate for UK employers developing their wellness strategy to address equity concerns directly:
1. Conditional Access is Key
UK employees strongly favor a cautious approach to access. 49% prefer conditional access programs limited to medical need, compared to only 27% who support universal availability. This preference aligns benefit provision with true clinical necessity, helping to mitigate the perception of a lifestyle perk for the privileged.
2. Medication Must Be Paired with Support
To ensure programs are sustainable and perceived as equitable, employers must treat GLP-1 access as one component of a holistic wellness plan, not a silver bullet. The core strategy must be pairing medication with inclusive, long-term nutrition guidance and support that benefits all employees, regardless of medication use.
3. Communicate Fairly and Clearly
Employers must proactively address equity concerns and clearly communicate how benefit decisions are made. By prioritizing transparency and long-term health habits, employers can ensure their programs are fair, sustainable, and support all employees in building lasting healthy routines.